Learning about psychosis in children with 22q11.2 deletion syndrome
Part of Blood & lymphatic, Bones, joints & muscles, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how “psychotic disorders” (like unusual beliefs, hallucinations, or thought changes) show up in children with 22q11.2 deletion syndrome. It mainly focuses on understanding the condition and may help improve care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have 22q11.2 deletion syndrome, or there is no developmental condition being studied
- Your child is between 4 and 13 years old
- You can do study activities in French
- Your child should not have an intellectual disability diagnosis based on DSM-5 criteria
- Your child should not take medicines for a physical (body) condition that could affect brain function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genetic differences affect how severe 22q11.2 deletion syndrome is for different people. It may help researchers understand what drives symptom severity and guide future care.
This study follows people with a rare genetic condition called 7q11.23 microduplication over time to understand how it affects development, learning, and health. Participants will have interviews, thinking and memory tests, and an MRI brain scan.
This study looks at how people at different stages of psychosis process sensory information like vision and hearing. It may help us understand early signs and improve treatments.
This trial looks at how thinking and mental health (psychiatric symptoms) show up in people who have a specific chromosome deletion. It may help researchers understand patterns in this condition and improve future care.
This study looks at how psychosis symptoms and development change over time in children and teens. It may help doctors better understand different patterns of illness and how to support young people with these disorders.
This study looks at how brain development and behavior may differ in people with a 3q29 deletion or 3q29 duplication. It may help researchers understand what to expect and how these conditions affect daily life.
Hear when a new 22q11.2 Deletion Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.